IL137810A0 - Vaccines comprising interleukin-12 and respiratory syncytial viral antigens - Google Patents

Vaccines comprising interleukin-12 and respiratory syncytial viral antigens

Info

Publication number: IL137810A0
Authority: IL; Israel
Prior art keywords: vaccines; interleukin; respiratory syncytial; viral antigens; syncytial viral
Prior art date: 1998-02-12

Application number

IL13781099A

Original Assignee

American Cyanamid Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-02-12

Filing date

1999-02-10

Publication date

2001-10-31

1999-02-10 Application filed by American Cyanamid Co filed Critical American Cyanamid Co

2001-10-31 Publication of IL137810A0 publication Critical patent/IL137810A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55538—IL-12
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Immunology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

IL13781099A 1998-02-12 1999-02-10 Vaccines comprising interleukin-12 and respiratory syncytial viral antigens IL137810A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US7445098P	1998-02-12	1998-02-12
PCT/US1999/002848 WO1999040937A2 (en)	1998-02-12	1999-02-10	Vaccines comprising interleukin-12 and respiratory syncytial viral antigens

Publications (1)

Publication Number	Publication Date
IL137810A0 true IL137810A0 (en)	2001-10-31

Family

ID=22119624

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13781099A IL137810A0 (en)	1998-02-12	1999-02-10	Vaccines comprising interleukin-12 and respiratory syncytial viral antigens

Country Status (9)

Country	Link
EP (1)	EP1053016A2 (en)
JP (1)	JP2002502883A (en)
KR (1)	KR20010040932A (en)
CN (1)	CN1295480A (en)
AU (1)	AU2596699A (en)
BR (1)	BR9907885A (en)
CA (1)	CA2320042A1 (en)
IL (1)	IL137810A0 (en)
WO (1)	WO1999040937A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000069456A2 (en)	1999-05-13	2000-11-23	American Cyanamid Company	Adjuvant combination formulations
MXPA02011737A (en)	2000-06-22	2003-03-27	American Cyanamid Co	Qs-21 and il-12 as an adjuvant combination.
US20030129161A1 (en) *	2001-09-17	2003-07-10	Hsien-Jue Chu	Interleukin-12 as a veterinary vaccine adjuvant
CN113832116B (en) *	2017-01-12	2024-09-13	厦门大学	Method for stabilizing respiratory syncytial virus fusion proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5571515A (en) *	1994-04-18	1996-11-05	The Wistar Institute Of Anatomy & Biology	Compositions and methods for use of IL-12 as an adjuvant
WO1996011019A1 (en) *	1994-10-05	1996-04-18	Vanderbilt University	Interleukin-12 as an adjuvant for paramyxoviridae vaccines
GB9422990D0 (en) *	1994-11-15	1995-01-04	Cortecs Ltd	Immunogenic compositions

1999
- 1999-02-10 IL IL13781099A patent/IL137810A0/en unknown
- 1999-02-10 CN CN99804658A patent/CN1295480A/en active Pending
- 1999-02-10 WO PCT/US1999/002848 patent/WO1999040937A2/en not_active Application Discontinuation
- 1999-02-10 EP EP99905925A patent/EP1053016A2/en not_active Withdrawn
- 1999-02-10 KR KR1020007008845A patent/KR20010040932A/en not_active Application Discontinuation
- 1999-02-10 JP JP2000531188A patent/JP2002502883A/en active Pending
- 1999-02-10 CA CA002320042A patent/CA2320042A1/en not_active Abandoned
- 1999-02-10 BR BR9907885-6A patent/BR9907885A/en not_active Application Discontinuation
- 1999-02-10 AU AU25966/99A patent/AU2596699A/en not_active Abandoned

Also Published As

Publication number	Publication date
WO1999040937A2 (en)	1999-08-19
WO1999040937A3 (en)	1999-10-28
CN1295480A (en)	2001-05-16
CA2320042A1 (en)	1999-08-19
KR20010040932A (en)	2001-05-15
AU2596699A (en)	1999-08-30
EP1053016A2 (en)	2000-11-22
JP2002502883A (en)	2002-01-29
BR9907885A (en)	2000-11-14

Similar Documents

Publication	Publication Date	Title
HUS1300050I1 (en)	2019-06-28	Adjuvant systems and vaccines
PL346213A1 (en)	2002-01-28	Immunological herpes simplex virus antigens and methods for use thereof
EP1112091A4 (en)	2001-08-01	Rapid cryobaric sterilization and vaccine preparation
HUP0201905A2 (en)	2002-09-28	Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
HUT74824A (en)	1997-02-28	Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome
EP1330220A4 (en)	2005-09-21	Sheet-shaped heating element and method for preparing the same
AU4932601A (en)	2001-10-03	Recombinant parainfluenza virus expression systems and vaccines
EP0674933A3 (en)	1995-11-22	Air filter material, its use and its preparation.
EP0958373A4 (en)	2001-11-28	Vaccines
GB9806666D0 (en)	1998-05-27	Antigen preparation and use
HUP0105392A3 (en)	2008-04-28	Enhanced vaccines
GB9410922D0 (en)	1994-07-20	Vaccines
HUP9901958A3 (en)	2000-04-28	Porcine reproductive and respiratory syndrome vaccine
EP0975363A4 (en)	2002-04-17	WEAKENED RESPIRATORY SYNCYTIAL VIRUS
IL137810A0 (en)	2001-10-31	Vaccines comprising interleukin-12 and respiratory syncytial viral antigens
EP1086215A4 (en)	2005-10-19	Preparation and use of superior vaccines
CZ20011896A3 (en)	2002-01-16	Immunogenic preparation and antibody
EP1023083A4 (en)	2006-06-14	Veterinary vaccines
IL141746A0 (en)	2002-03-10	Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus
GB0105606D0 (en)	2001-04-25	Immunogens and vaccines and their preparation and use
ZA997265B (en)	2001-05-23	Leptospira vaccine antigens for the prevention of leptospirosis.
IL143100A0 (en)	2002-04-21	Contraceptive antibody vaccines
HK1047943A1 (en)	2003-03-14	Moraxella cattarrhalis basb114 antigens and uses thereof
GB9611334D0 (en)	1996-08-07	Viral antigens and their preparation
GC0000133A (en)	2005-06-29	Combination vaccine against streptococcus preumoniae and respiratory syncytial virus (rsv).